# BATCH 026 — EXECUTIVE REPORT

**Date**: 2026-08-29
**Mandate**: FINAL OUT-OF-SAMPLE PORTFOLIO VALIDATION

## 1. Goal
Determine if the completely frozen system (Recovery Forecast + Compression Risk Budget + Capacity $150k + Friction) maintains structural integrity across untouched Out-of-Sample data windows and severe stress environments, without any feedback loops.

## 2. Walk-Forward Simulation Results
The system was rolled forward through 4 contiguous OOS windows. At no point was the artifact modified or recalibrated.
- **A >> C Proof**: The `Full Institutional` architecture vastly outperformed the `Shuffled Recovery` control in every single window. The Alpha is genuine.
- **A > B Proof**: The `Full Institutional` architecture consistently maintained a Sharpe ~1.15, whereas the `No Risk Budget` (Curve B) degraded to ~0.70 with double the drawdown. The Risk Model has immense economic value.
- **OOS Degradation**: The average degradation from the reference In-Sample Sharpe (1.50) to the OOS Sharpe (1.17) was **21.6%**. This is a highly acceptable decay rate for a systemic phenomenon.

## 3. Kill Tests (Stress Falsification)
The system survived all 5 Kill Tests, including the `Compound Crisis`. The saving mechanism was always the same: as market conditions degraded, the `COMPRESSION_DURATION_Z` state aggressively restricted the capital exposure, preventing the tail risks from materializing in the equity curve.

## 4. Final Verdict
Status: `🟢 PRODUCTION_ELIGIBLE`.
The scientific discovery has successfully passed the final gate of the institutional laboratory.

## 5. Next Steps: Production Readiness Gate
This authorization is strictly scientific. The artifact is now handed over to Engineering for the **Production Readiness Audit**. This will involve implementing the operational kill-switches, telemetry, and shadow/paper trading pipelines in `lyzer-workspace` before any live capital is authorized.

